opc 12759 has been researched along with sodium dodecyl sulfate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanamitsu, K; Kikuchi, A; Maeda, T; Odomi, M; Sasabe, H; Tamai, I; Tanaka, M; Tomoyasu, T | 1 |
| Hanawa, T; Kawano, Y | 1 |
1 review(s) available for opc 12759 and sodium dodecyl sulfate
| Article | Year |
|---|---|
[Development of Hospital Formulations Based on Medical Need].
Topics: Alanine; Cellulose; Chemical Phenomena; Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Humans; Mouthwashes; Nanoparticles; Pharmacy Service, Hospital; Quinolones; Radiotherapy; Sodium Dodecyl Sulfate; Solubility; Solutions; Stomatitis | 2019 |
1 other study(ies) available for opc 12759 and sodium dodecyl sulfate
| Article | Year |
|---|---|
Peptide derivation of poorly absorbable drug allows intestinal absorption via peptide transporter.
Topics: Alanine; Animals; Biological Availability; Caco-2 Cells; Chromatography, High Pressure Liquid; Dipeptides; Enzyme Inhibitors; Glutamine; HeLa Cells; Humans; In Vitro Techniques; Indicators and Reagents; Intestinal Absorption; Intestinal Mucosa; Intestines; Oocytes; Patch-Clamp Techniques; Peptide Transporter 1; Peptides; Quinolones; Rats; Regional Blood Flow; Sodium Dodecyl Sulfate; Symporters; Taurine; Xenopus | 2009 |